Summary

Global Biophotonics Market is valued approximately USD 70.4 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 10.50 % over the forecast period 2024-2032. Biophotonics is the study of producing and applying light to see, sense, and operate biological elements. It makes use of light and other radiant energy sources to comprehend how living things' interior organs and cell’s function. Biology uses biophotonics to investigate the structures, functions, and processes of molecules. In order to identify, and cure diseases, light-tissue interactions at the micro, nano, and macro-organism levels are studied in medicine. Additionally, it facilitates the emission, detection, absorption, modification, and synthesis of radiation from biomaterials, cells, tissues, and animals as well as bimolecular structures. There is a growing demand for portable and point-of-care biophotonic devices that can be used in remote or resource-limited settings. The key trend such as technological advanced biophotonics devices enable rapid, on-site diagnostics and monitoring, making healthcare more accessible and convenient. Thus, this trend further supports growth of the Global Biophotonics Market during the forecast period 2024-2032.

The rising incidence of chronic diseases such as cancer, cardiovascular diseases, and diabetes is a significant driver for the Global Biophotonics Market. As these conditions become more prevalent, there is an increasing need for advanced diagnostic and therapeutic technologies that biophotonics can provide. Biophotonic techniques offer non-invasive, highly accurate methods for early disease detection and monitoring, crucial for effective management and treatment. For instance, optical coherence tomography (OCT) enables detailed imaging of cardiovascular tissues, while fluorescence imaging aids in identifying cancerous cells at early stages. Additionally, biophotonics supports personalized medicine by offering precise diagnostic information tailored to individual patient profiles, leading to better-targeted treatments. This growing demand for sophisticated diagnostic tools and effective treatment options, driven by the global burden of chronic diseases, propels the expansion and innovation within the Biophotonics Market. However, high cost of equipment and complexity of technology stifle market growth during the forecast period 2024-2032.

The key regions considered for the global Biophotonics market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America was the largest regional market in terms of revenue. The North American biophotonics market is driven by technological advancements, rising healthcare needs, and supportive regulatory environments. As the region remains at the forefront of biomedical research and innovation, biophotonics will play an increasingly vital role in addressing healthcare challenges and improving patient outcomes. Despite challenges such as cost constraints and regulatory compliance, ongoing developments in personalized medicine, AI integration, and point-of-care diagnostics position biophotonics as a key driver of innovation in healthcare delivery. Moreover, the rising incidence of chronic diseases, such as cancer, cardiovascular diseases, and diabetes, fuels the demand for advanced diagnostic and therapeutic solutions. Biophotonics offers precise, non-invasive techniques for early detection, monitoring, and treatment of these conditions. Furthermore, the market in Asia Pacific is expected to develop at the fastest rate over the forecast period.

Major market player included in this report are:
Thermo Fisher Scientific Inc.
Oxford Technologies
Carl Zeiss AG
Glenbrook Technologies Inc.
Becton, Dickinson and Company
Hamamatsu Photonics K.K.
Lumenis Ltd.
Olympus Corporation
PerkinElmer Inc.
Zenalux Biomedical Inc.

The detailed segments and sub-segment of the market are explained below:

By End User
Medical Diagnostics
Medical Therapeutic
Tests & Components
Nonmedical Application

By Application
See-through Imaging
Inside Imaging
Spectro Molecular
Surface Imaging
Microscopy
Light Therapy
Analytical Sensing
Biosensors

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
RoMEA

Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032

Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

ページTOPに戻る

Table of Contents

Chapter 1. Global Biophotonics Market Definition and Research Assumptions
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates

Chapter 2. Executive Summary
2.1. Global Biophotonics Market Size & Forecast (2022- 2032)
2.2. Regional Summary
2.3. Segmental Summary
2.3.1. By End User
2.3.2. By Application
2.4. Key Trends
2.5. Recession Impact
2.6. Analyst Recommendation & Conclusion
Chapter 3. Global Biophotonics Market Dynamics
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
Chapter 4. Global Biophotonics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Biophotonics Market Size & Forecasts by End User 2022-2032
5.1. Medical Diagnostics
5.2. Medical Therapeutic
5.3. Tests & Components
5.4. Nonmedical Application
Chapter 6. Global Biophotonics Market Size & Forecasts by Application 2022-2032
6.1. See-through Imaging
6.2. Inside Imaging
6.3. Spectro Molecular
6.4. Surface Imaging
6.5. Microscopy
6.6. Light Therapy
6.7. Analytical Sensing
6.8. Biosensors
Chapter 7. Global Biophotonics Market Size & Forecasts by Region 2022-2032
7.1. North America Biophotonics Market
7.1.1. U.S. Biophotonics Market
7.1.1.1. End User breakdown size & forecasts, 2022-2032
7.1.1.2. Application breakdown size & forecasts, 2022-2032
7.1.2. Canada Biophotonics Market
7.2. Europe Biophotonics Market
7.2.1. U.K. Biophotonics Market
7.2.2. Germany Biophotonics Market
7.2.3. France Biophotonics Market
7.2.4. Spain Biophotonics Market
7.2.5. Italy Biophotonics Market
7.2.6. Rest of Europe Biophotonics Market
7.3. Asia-Pacific Biophotonics Market
7.3.1. China Biophotonics Market
7.3.2. India Biophotonics Market
7.3.3. Japan Biophotonics Market
7.3.4. Australia Biophotonics Market
7.3.5. South Korea Biophotonics Market
7.3.6. Rest of Asia Pacific Biophotonics Market
7.4. Latin America Biophotonics Market
7.4.1. Brazil Biophotonics Market
7.4.2. Mexico Biophotonics Market
7.4.3. Rest of Latin America Biophotonics Market
7.5. Middle East & Africa Biophotonics Market
7.5.1. Saudi Arabia Biophotonics Market
7.5.2. South Africa Biophotonics Market
7.5.3. Rest of Middle East & Africa Biophotonics Market
Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. Company 1
8.1.2. Company 2
8.1.3. Company 3
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Thermo Fisher Scientific Inc.
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Market Strategies
8.3.2. Oxford Technologies
8.3.3. Carl Zeiss AG
8.3.4. Glenbrook Technologies Inc.
8.3.5. Becton, Dickinson and Company
8.3.6. Hamamatsu Photonics K.K.
8.3.7. Lumenis Ltd.
8.3.8. Olympus Corporation
8.3.9. PerkinElmer Inc.
8.3.10. Zenalux Biomedical Inc.
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes